Continuous Glucose Monitoring in At-Risk Newborns — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Continuous Glucose Monitoring in At-Risk Newborns — Stella

Recruiting

Back to Neonatal Hypoglycemia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Penn State Health Milton S Hershey Medical Center, Hershey, Pennsylvania

Key details

Sponsor

Milton S. Hershey Medical Center

Collaborators

DexCom, Inc., Children's Miracle Network

Enrollment target

~100 participants

Started

August 2021

Primary completion

June 2026

Age range

1 Minute – 2 Weeks

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov